Li G, Cui J, He S, Feng X, Li W, Li T
Heliyon. 2024; 10(20):e39021.
PMID: 39640638
PMC: 11620054.
DOI: 10.1016/j.heliyon.2024.e39021.
Zhong L, Wu J, Zhou B, Kang J, Wang X, Ye F
NPJ Precis Oncol. 2024; 8(1):243.
PMID: 39455812
PMC: 11512073.
DOI: 10.1038/s41698-024-00737-0.
Webster S, Ghalei H
RNA Biol. 2023; 20(1):715-736.
PMID: 37796118
PMC: 10557570.
DOI: 10.1080/15476286.2023.2254540.
Song L, Wang S, Li Q, Lu Y, Yang R, Feng X
J Oncol. 2023; 2023:9931419.
PMID: 36936373
PMC: 10017215.
DOI: 10.1155/2023/9931419.
Tang F, Liu Y, Sun Y, Xiong Y, Gu Y, Zhou J
Front Endocrinol (Lausanne). 2023; 14:1099703.
PMID: 36777349
PMC: 9911864.
DOI: 10.3389/fendo.2023.1099703.
Comprehensive analysis of key m5C modification-related genes in type 2 diabetes.
Song Y, Jiang Y, Shi L, He C, Zhang W, Xu Z
Front Genet. 2022; 13:1015879.
PMID: 36276976
PMC: 9582283.
DOI: 10.3389/fgene.2022.1015879.
A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma.
Li J, Liu X, Qi Y, Liu Y, Du E, Zhang Z
Front Immunol. 2022; 13:922929.
PMID: 36189275
PMC: 9524857.
DOI: 10.3389/fimmu.2022.922929.
The role of RNA modification in hepatocellular carcinoma.
Feng Q, Wang D, Xue T, Lin C, Gao Y, Sun L
Front Pharmacol. 2022; 13:984453.
PMID: 36120301
PMC: 9479111.
DOI: 10.3389/fphar.2022.984453.
Identification of the crosstalk among four types of adenosine-related RNA modification in pan-cancer.
Zhang S, Xiong Y, Wang W, Zhang E, Gu Y, Liu Y
Cancer Sci. 2022; 113(10):3633-3636.
PMID: 35965405
PMC: 9530861.
DOI: 10.1111/cas.15503.
Integrated Bioinformatics Analysis of Serine Racemase as an Independent Prognostic Biomarker in Endometrial Cancer.
Cui Z, Mo J, Wang L, Wang R, Cheng F, Wang L
Front Genet. 2022; 13:906291.
PMID: 35923695
PMC: 9340001.
DOI: 10.3389/fgene.2022.906291.
Advances in RNA Epigenetic Modifications in Hepatocellular Carcinoma and Potential Targeted Intervention Strategies.
Zhu L, Ni W, Cai M, Dai W, Zhou H
Front Cell Dev Biol. 2021; 9:777007.
PMID: 34778277
PMC: 8586511.
DOI: 10.3389/fcell.2021.777007.
Comprehensive Analysis of the Prognostic Value and Immune Infiltrates of the Three-m5C Signature in Colon Carcinoma.
Geng Q, Wei Q, Shen Z, Zheng Y, Wang L, Xue W
Cancer Manag Res. 2021; 13:7989-8002.
PMID: 34707405
PMC: 8542737.
DOI: 10.2147/CMAR.S331549.